Open an account

Kestra Medical Technologies

KMTS · NASDAQ

$28.28−$1.09 (−3.71%)TodayMarket closed ·
Prev close $29.37

About KMTS

Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. The company is headquartered in Kirkland, Washington and currently employs 330 full-time employees. The company went IPO on 2025-03-06. The firm has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The firm's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Employees
330
Headquarters
Kirkland, Washington
Listed
Mar 6, 2025
Sector
Health Care
Industry
Health Care Equipment & Supplies

KMTS key statistics

Market cap
1.75B
Price-earnings ratio
0.00
Dividend yield
—
Average volume
331.98K
Volume
454.81K
Open price
$29.75
High today
$29.94
Low today
$28.22
52 Week high
$30.00
52 Week low
$17.34

Kestra Medical Technologies (KMTS) at a glance

Kestra Medical Technologies (KMTS) last traded at $28.28, with a market cap of 1.75B and a price-to-earnings ratio of 0.00.

Today the stock has traded between $28.22 and $29.94. The current price is 0.2% above the day's low and 5.5% below its high.

Volume so far is 454.81K shares, above the average of 331.98K shares a day.

Over the past year Kestra Medical Technologies has ranged from $17.34 to $30.00, and now sits 86% of the way up that range.

Kestra Medical Technologies met or beat analyst EPS estimates in 1 of the last 6 quarters. In Q1 FY27 it reported -$0.65 per share against an estimate of -$0.6282.

The average analyst price target is $30.94, 9.4% above the current price, from 7 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

71%of 7 analyst ratings say Buy
  • Buy71.4%
  • Hold28.6%
  • Sell0.0%
Price target · 9 analystsAvg $30.94
Low
$28.28
Now
$28.28
High
$33.60

KMTS earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 6 quarters, by 42.1% on average.

  1. Q4 FY25: reported -$2.21 per share against an estimate of -$0.5355
  2. Q1 FY26: reported -$0.447 per share against an estimate of -$0.7718
  3. Q2 FY26: reported -$0.64 per share against an estimate of -$0.6047
  4. Q3 FY26: reported -$0.61 per share against an estimate of -$0.6076
  5. Q4 FY26: reported -$0.67 per share against an estimate of -$0.6076
  6. Q1 FY27: reported -$0.65 per share against an estimate of -$0.6282

KMTS news

  • Press releaseBusiness Wire

    CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directors

  • 12 Health Care Stocks Moving In Tuesday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseBusiness Wire

    Biobeat Technologies Names Raymond W. Cohen as Chairman of the Board of Directors

  • Press releaseBusiness Wire

    Omega Funds Closes Oversubscribed $647 Million Fund VIII to Invest in Transformative Life Science Companies

  • Press releasePRNewswire

    Archimedes Vascular Announces Close of Series A Financing led by Sherpa Healthcare Partners and Appoints Raymond W. Cohen as Chairman of its Board of Directors

  • Press releaseGlobe Newswire

    Kestra Medical Technologies Reports Third Quarter Fiscal 2025 Financial Results

  • Press releaseBusiness Wire

    Nalu Medical Appoints Veteran Medtech Executive Raymond W. Cohen Chairman of its Board of Directors

Similar companies

Companies in the same industry as Kestra Medical Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.